by In2Pharma | Jul 13, 2026 | News
Luxembourg On 10 June 2026, the General Assembly of Innovative Medicines for Luxembourg (IML) approved a revised version of the IML Code of Ethics. The updated code introduces several targeted changes, including new provisions on complaints, a dedicated patient...
by In2Pharma | Jun 2, 2026 | News
Luxembourg There is a new law in Luxembourg on materials and articles intended to come into contact with food, in line with Regulation (EU) 2017/625. This law also sets out the activities and controls carried out by the Luxembourg Veterinary and Food Administration...
by In2Pharma | Mar 6, 2026 | News
Luxembourg From 1 January 2026, nicotine pouches and other novel nicotine-containing products will fall under the same regulatory framework as traditional tobacco products. The new rules introduce a ban on advertising, prohibit the free distribution of these...
by In2Pharma | Jan 5, 2026 | News
Luxembourg The LU agency (DPM) has updated its internal guidance document outlining all steps related to market authorization procedures in Luxembourg. Key Amendments: Decentralised, Mutual Recognition, and Repeat Use Procedures (MRP/DCP/RUP) Variations Type IA / Type...
by In2Pharma | Oct 17, 2025 | News
Luxembourg As part of the pharmacovigilance system, the marketing authorization holder has at its disposal, on a permanent and continuous basis, an appropriately qualified person responsible for pharmacovigilance. The person responsible for pharmacovigilance resides...
